Kenvue (KVUE) Competitors $21.35 +0.43 (+2.06%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$21.26 -0.09 (-0.40%) As of 07/11/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock KVUE vs. JNJ, UL, HLN, SN, ELF, COTY, ODD, MBC, IMAX, and EPCShould you be buying Kenvue stock or one of its competitors? The main competitors of Kenvue include Johnson & Johnson (JNJ), Unilever (UL), Haleon (HLN), SharkNinja (SN), e.l.f. Beauty (ELF), Coty (COTY), ODDITY Tech (ODD), MasterBrand (MBC), IMAX (IMAX), and Edgewell Personal Care (EPC). Kenvue vs. Its Competitors Johnson & Johnson Unilever Haleon SharkNinja e.l.f. Beauty Coty ODDITY Tech MasterBrand IMAX Edgewell Personal Care Johnson & Johnson (NYSE:JNJ) and Kenvue (NYSE:KVUE) are related large-cap companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability. Is JNJ or KVUE more profitable? Johnson & Johnson has a net margin of 24.42% compared to Kenvue's net margin of 6.90%. Johnson & Johnson's return on equity of 33.46% beat Kenvue's return on equity.Company Net Margins Return on Equity Return on Assets Johnson & Johnson24.42% 33.46% 13.30% Kenvue 6.90%20.87%8.04% Is JNJ or KVUE a better dividend stock? Johnson & Johnson pays an annual dividend of $5.20 per share and has a dividend yield of 3.3%. Kenvue pays an annual dividend of $0.82 per share and has a dividend yield of 3.8%. Johnson & Johnson pays out 57.8% of its earnings in the form of a dividend. Kenvue pays out 149.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Johnson & Johnson has raised its dividend for 64 consecutive years and Kenvue has raised its dividend for 1 consecutive years. Do analysts recommend JNJ or KVUE? Johnson & Johnson currently has a consensus price target of $171.00, suggesting a potential upside of 9.01%. Kenvue has a consensus price target of $25.33, suggesting a potential upside of 18.66%. Given Kenvue's higher possible upside, analysts plainly believe Kenvue is more favorable than Johnson & Johnson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Johnson & Johnson 0 Sell rating(s) 11 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.55Kenvue 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42 Which has more risk and volatility, JNJ or KVUE? Johnson & Johnson has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Kenvue has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Does the media refer more to JNJ or KVUE? In the previous week, Johnson & Johnson had 102 more articles in the media than Kenvue. MarketBeat recorded 119 mentions for Johnson & Johnson and 17 mentions for Kenvue. Kenvue's average media sentiment score of 1.62 beat Johnson & Johnson's score of 1.32 indicating that Kenvue is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Johnson & Johnson 100 Very Positive mention(s) 3 Positive mention(s) 11 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Positive Kenvue 16 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do institutionals & insiders have more ownership in JNJ or KVUE? 69.6% of Johnson & Johnson shares are held by institutional investors. Comparatively, 97.6% of Kenvue shares are held by institutional investors. 0.2% of Johnson & Johnson shares are held by company insiders. Comparatively, 1.7% of Kenvue shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better valuation & earnings, JNJ or KVUE? Johnson & Johnson has higher revenue and earnings than Kenvue. Johnson & Johnson is trading at a lower price-to-earnings ratio than Kenvue, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJohnson & Johnson$88.82B4.25$14.07B$8.9917.45Kenvue$15.46B2.65$1.03B$0.5538.82 SummaryJohnson & Johnson beats Kenvue on 13 of the 20 factors compared between the two stocks. Get Kenvue News Delivered to You Automatically Sign up to receive the latest news and ratings for KVUE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KVUE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KVUE vs. The Competition Export to ExcelMetricKenvueCONS PD IndustryStaples SectorNYSE ExchangeMarket Cap$40.94B$33.51B$16.22B$20.65BDividend Yield3.84%2.62%3.11%3.72%P/E Ratio38.8232.3219.7827.84Price / Sales2.651.8345.9942.29Price / Cash14.5016.2414.7022.32Price / Book4.248.736.104.57Net Income$1.03B$1.19B$680.31M$989.30M7 Day Performance1.59%-0.56%2.16%0.20%1 Month Performance-0.43%4.18%3.64%5.53%1 Year Performance16.41%31.55%4.30%10.30% Kenvue Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KVUEKenvue3.4108 of 5 stars$21.35+2.1%$25.33+18.7%+16.4%$40.94B$15.46B38.8222,000Positive NewsJNJJohnson & Johnson4.8126 of 5 stars$155.23-0.5%$170.88+10.1%+4.7%$373.49B$88.82B17.27138,100Trending NewsUpcoming EarningsAnalyst ForecastULUnilever3.4008 of 5 stars$61.40+0.0%$70.67+15.1%+5.5%$150.71B$65.76B17.59115,964Positive NewsHLNHaleon3.5617 of 5 stars$10.16-0.9%$12.33+21.3%+11.9%$45.66B$14.35B26.0524,561News CoverageAnalyst DowngradeSNSharkNinja1.3993 of 5 stars$105.50-1.6%$121.50+15.2%+50.5%$14.88B$5.53B33.393,688ELFe.l.f. Beauty4.4913 of 5 stars$122.38-6.6%$118.88-2.9%-47.8%$6.89B$1.31B63.41300Positive NewsAnalyst ForecastCOTYCoty4.366 of 5 stars$4.97-2.4%$7.80+56.9%-51.4%$4.33B$6.12B-10.3511,791ODDODDITY Tech0.6079 of 5 stars$76.02+0.1%$61.75-18.8%+69.0%$4.24B$647.04M43.69342Positive NewsMBCMasterBrand2.7333 of 5 stars$11.36-2.1%$15.00+32.0%-22.7%$1.44B$2.70B14.5613,000IMAXIMAX4.0822 of 5 stars$26.58-2.8%$31.70+19.3%+54.2%$1.43B$352.21M56.55780Trending NewsAnalyst ForecastAnalyst RevisionEPCEdgewell Personal Care3.7266 of 5 stars$24.51-0.4%$33.00+34.6%-32.6%$1.15B$2.25B14.336,700Positive News Related Companies and Tools Related Companies JNJ Alternatives UL Alternatives HLN Alternatives SN Alternatives ELF Alternatives COTY Alternatives ODD Alternatives MBC Alternatives IMAX Alternatives EPC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:KVUE) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kenvue Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kenvue With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.